Aquiles Carattino logo

Extracellular vesicles as markers for prostate cancer

First published:

Last Edited:

Number of edits:

Extracelluar vesicles can be used as markers for prostate cancer. The general idea is that patients with cancer will have a higher abundance of exosomes with CD9 and CD63, therefore if it would be possible to quantify the amount of these proteins, they would become a clear path to diagnosis.

One possible path is to combine TR-FIA with europium labeling[@duijvesz2015aImmuno-based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer: Extracellular vesicles as marker for PCa]. An essay similar to Elisa tests with fluorescence is able to quantify the amount of CD9 and CD63 in urine samples from patients with and without prostate cancer.

Europium-based detection of CD9 and CD63 in urine samples

The overall idea is that quantifying the concentration of CD9 and CD63, it is possible to have a better diagnostic tool than by just looking at PSA levels.


These are the other notes that link to this one.


Join my experiment of better thinking and interesting discussions
Aquiles Carattino
Aquiles Carattino
This note you are reading is part of my digital garden. Follow the links to learn more, and remember that these notes evolve over time. After all, this website is not a blog.
© 2021 Aquiles Carattino
Privacy Policy
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.